Severe asthma — breaking the cycle of inadequate care
DNYUZ,
Asthma has long lagged behind other inflammatory conditions in terms of political attention and progress on patient outcomes.
Asthma has long lagged behind other inflammatory conditions in terms of political attention and progress on patient outcomes.
The real cost of severe asthma: Why urgent action is needed to protect patients and reduce the strain on stretched health…
Published date: 28/03/2023 London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for…
Tezspire (tezepelumab) is a first-in-class and will be the only biologic medicine to have no phenotype or biomarker limitation…